Testing a new blood pressure medicine in healthy and mildly hypertensive people
Part of Heart & circulation clinical trials.
This early-stage trial tests a new oral medication (HS-10522) to see if it is safe and how the body handles it. It includes both healthy people and those with mild high blood pressure, and may help lower blood pressure in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old
- You are Chinese and either healthy or have mild high blood pressure
- Your weight is at least 50 kg for men or 45 kg for women
- Your body mass index (BMI) is between 19 and 28
- You have not taken any medication in the last 2 weeks
- You have no major health problems like thyroid or kidney disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage trial tests a new blood pressure medication called HJB647 in Japanese adults with elevated or high blood pressure. The study aims to see if the drug is safe and how the body handles it.
This study tests a new blood pressure medication to see if it is safe and effective for people with high blood pressure. It may help lower your blood pressure and reduce health risks.
This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.
This trial tests a new treatment called CTX340 for high blood pressure that is hard to control even with multiple medications. The study aims to see if it is safe and effective.
This trial tests a new drug called SAL0140 for people whose high blood pressure is not controlled by current treatments. It may help lower blood pressure when other medications haven't worked well enough.
This early-stage study tests a new investigational drug called QLS1410 in healthy adults and people with mild high blood pressure. The goal is to see how the drug works and if it is safe.
Hear when a new High blood pressure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.